# MediCare Clinical Safety Plan — Phase 13

**Status:** Specification only; no AI capability is active.

## Safety classification

Any future MediCare AI capability is **Clinical Decision Support / Informational Assistance**. It is not autonomous diagnosis, autonomous treatment, prescription generation, dosage selection, medical-record modification, test ordering, or physician replacement.

## Human oversight

A qualified clinician must review any future clinical-support result before it influences care. The user interface and API must show the task, model/version, limitations, uncertainty or abstention, evidence/provenance where relevant, and a clear statement that qualified professional judgment is required.

## Misuse risks

Potential misuse includes treating an informational result as a diagnosis, using an out-of-scope population, acting on a low-quality or stale report, ignoring missing inputs, sharing a patient result with an unauthorized person, converting a probability into certainty, and using a recommendation without clinical review. The future system must constrain scope and record review/escalation decisions where required.

## Error risks

False positives may create unnecessary anxiety, testing, referrals, or treatment pressure. False negatives may delay evaluation or falsely reassure a patient. Label error, dataset shift, missingness, measurement bias, and unsupported generalization can increase both risks. No threshold may be selected solely to optimize a headline metric.

## Required controls

Future implementation must validate input, ownership, role, task scope, model/version availability, output schema, warnings, provenance, and disclaimer. It must abstain or return a safe error when information is missing, the task is unsupported, the model is unavailable, the input is out of distribution, or an unsafe claim is detected.

## Escalation

Urgent symptoms or potentially serious findings must not be handled as routine AI recommendations. The product must direct users to appropriate professional or emergency care according to approved clinical content. No Phase 13 emergency protocol is invented.

## Prohibited behavior

The system must never diagnose, prescribe, change medication, modify records, order tests, approve treatment, expose another patient’s information, or imply certainty. It must not use real patient data for model development without explicit governance approval.


## Phase 16 task-specific addendum

The selected capability is an academic classifier of the UCI Heart Disease dataset label. It must not be described as a diagnosis, prognosis, treatment recommendation, or patient-specific risk assessment. The source label transformation is `num=0` to label absent and `num=1..4` to label present; this semantics must be shown in model documentation and never silently reworded as clinical certainty.

Phase 16 creates no inference endpoint and exposes no output to MediCare users. A future inference path must fail closed for missing or invalid features, unsupported categories, out-of-range values, schema mismatch, unavailable artifacts, or version mismatch. It must not accept MediCare patient IDs or silently read clinical tables.

Any future integration requires explicit owner approval, data/license verification, privacy and security review, bias/fairness review, held-out evaluation, explanation review, human oversight, and safe UI copy. No result may trigger autonomous care, prescription, record modification, emergency triage, or workflow action.
